Applied Dna Sciences (NASDAQ:BNBX) Posts Quarterly Earnings Results

Applied Dna Sciences (NASDAQ:BNBXGet Free Report) announced its quarterly earnings data on Friday. The company reported ($0.68) earnings per share (EPS) for the quarter, Zacks reports.

Applied Dna Sciences Price Performance

Shares of BNBX stock opened at $0.44 on Friday. Applied Dna Sciences has a 12 month low of $0.44 and a 12 month high of $12.09. The firm has a market cap of $2.49 million, a price-to-earnings ratio of 0.00 and a beta of 0.58. The business has a fifty day moving average price of $0.62.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Check Out Our Latest Stock Report on Applied Dna Sciences

About Applied Dna Sciences

(Get Free Report)

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.

Featured Articles

Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.